an independent special committee for the board of pasithea therapeutics has rejected a buyout offer from lucy scientific discovery the biotechnology company said thursday that the proposal in which lucy scientific would acquire each pasithea share for 60 cents in cash and 25 cents of its own common stock isnt in its best interest and doesnt reflect pasitheas strategic value separately pasithea said thursday that it plans to launch a 4 million tender offer for up to 57 million of its own shares at an anticipated purchase price of 70 cents a share the offering is expected to close in the third quarter pasithea shares jumped 23 to 58 cents in premarket trading shares of lucy scientific slipped 16 to 122